MedPath

The New York State Psychiatric Institute

The New York State Psychiatric Institute logo
🇺🇸United States
Ownership
Private
Established
1895-01-01
Employees
251
Market Cap
-
Website
http://www.nyspi.org

An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD

Not Applicable
Terminated
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
First Posted Date
2014-10-08
Last Posted Date
2023-02-02
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
38
Registration Number
NCT02259517
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)

Phase 2
Withdrawn
Conditions
Depersonalization Disorder
Interventions
Device: Daily rTMS with Sham coil
Device: Daily rTMS with Active coil
Device: Open Label Daily rTMS with Active coil
First Posted Date
2014-10-03
Last Posted Date
2017-03-24
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT02256085
Locations
🇺🇸

New York State Psychiatric Institute, Experimental Therapeutics, New York, New York, United States

🇺🇸

Sophie Davis School of Biomedical Education, City University of New York (CUNY), New York, New York, United States

Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.

Phase 2
Completed
Conditions
Cocaine Dependence
Interventions
First Posted Date
2014-10-02
Last Posted Date
2023-06-05
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
43
Registration Number
NCT02255357
Locations
🇺🇸

Substance Treatment and Research Service (STARS), Manhattan, New York, United States

🇺🇸

Divison on Substance Abuse - Albert Einstein College of Medicine, Bronx, New York, United States

Biosignatures of Latuda for Bipolar Depression

Not Applicable
Completed
Conditions
Bipolar Depression
Interventions
First Posted Date
2014-09-12
Last Posted Date
2017-12-12
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
20
Registration Number
NCT02239094
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Psychotherapy for Depressed or Anxious Adolescents With Cancer

Not Applicable
Withdrawn
Conditions
Depression
Anxiety
Cancer
Interventions
Behavioral: Behavioral activation therapy
First Posted Date
2014-09-05
Last Posted Date
2015-10-07
Lead Sponsor
New York State Psychiatric Institute
Registration Number
NCT02232438
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Control and Reward Circuits in Obsessive Compulsive Disorder

Not Applicable
Completed
Conditions
Obsessive-Compulsive Disorder
Interventions
Behavioral: Exposure & Response Prevention (EX/RP)
First Posted Date
2014-08-20
Last Posted Date
2019-03-13
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
80
Registration Number
NCT02221518
Locations
🇺🇸

NY State Psychiatric Institute, New York, New York, United States

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

Phase 2
Terminated
Conditions
Obsessive-Compulsive Disorder
Interventions
First Posted Date
2014-08-01
Last Posted Date
2017-05-03
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
2
Registration Number
NCT02206776
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep

Not Applicable
Terminated
Conditions
Generalized Anxiety Disorder
Social Phobia
Separation Anxiety Disorder
Interventions
First Posted Date
2014-07-14
Last Posted Date
2021-10-11
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
14
Registration Number
NCT02189213
Locations
🇺🇸

NYSPI, New York, New York, United States

Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS

Not Applicable
Completed
Conditions
HIV Infection
Fatigue
Interventions
Behavioral: Behavioral Activation Counseling
First Posted Date
2014-05-16
Last Posted Date
2020-03-16
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
138
Registration Number
NCT02140775
Locations
🇺🇸

Callen-Lorde Community Health Center, New York, New York, United States

🇺🇸

New York State Psychiatric Institute, New York, New York, United States

Biomarker Assessment of Glutamatergic Target Engagement

Phase 4
Completed
Conditions
Healthy Controls
Interventions
Drug: Normal saline
First Posted Date
2014-05-09
Last Posted Date
2018-08-17
Lead Sponsor
New York State Psychiatric Institute
Target Recruit Count
65
Registration Number
NCT02134951
Locations
🇺🇸

University of California Davis, Sacramento, California, United States

🇺🇸

New York State Psychiatric Institute, New York, New York, United States

🇺🇸

Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath